NFE2L2 and colorectal carcinoma: Further IP-MS and Co-IP analyses indicated that PRDX1 could interact with cullin-3 (CUL3) as a molecular chaperone, suppress NRF2 ubiquitination-mediated degradation and induce NRF2 nuclear translocation, thereby promoting CRC progression by inhibiting ferroptosis.